Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lurasidone 74mg tablets
0402010AIAAACAC
|
Lurasidone | Lurasidone | Central Nervous System | 6,125 |
|
Lurasidone 37mg tablets
0402010AIAAABAB
|
Lurasidone | Lurasidone | Central Nervous System | 5,344 |
|
Lurasidone 18.5mg tablets
0402010AIAAAAAA
|
Lurasidone | Lurasidone | Central Nervous System | 2,222 |
|
Latuda 74mg tablets
0402010AIBBACAC
|
Latuda | Lurasidone | Central Nervous System | 104 |
|
Latuda 37mg tablets
0402010AIBBABAB
|
Latuda | Lurasidone | Central Nervous System | 48 |
|
Latuda 18.5mg tablets
0402010AIBBAAAA
|
Latuda | Lurasidone | Central Nervous System | 21 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.